Header_Esophagus_to_Small_Intestine

Esophagus to Small Intestine

endoscopía_cápsula_de_Bowel

Capsule endoscopy-guided proactive treat-to-target therapy for patients with quiescent small intestinal Crohn’s disease
08/2025

Capsule endoscopy-guided proactive treat-to-target therapy for patients with quiescent small intestinal Crohn’s disease

esófago_endoscopía

Etrasimod as a treatment for eosinophilic oesophagitis
08/2025

Etrasimod as a treatment for eosinophilic oesophagitis

crohns_disease

Upadacitinib for fistulizing Crohn’s disease
06/2025

Upadacitinib for fistulizing Crohn’s disease

obesity_worldwide

Dramatic increase in obesity worldwide
06/2025

Dramatic increase in obesity worldwide

healthy_aging

Optimal diets for healthy aging
05/2025

Optimal diets for healthy aging

tnf_antibody_therapy_protects

Early TNF antibody therapy protects against disease progression and perianal fistulas in Crohn's disease
05/2025

Early TNF antibody therapy protects against disease progression and perianal fistulas in Crohn's disease

Crohn’s_disease

Prior appendectomy and clinical disease course of Crohn’s disease
04/2025

Prior appendectomy and clinical disease course of Crohn’s disease

barretts_esophagus

Liquid biopsy to identify Barrett’s esophagus
04/2025

Liquid biopsy to identify Barrett’s esophagus

chronic-inflammatory-bowel-disease.jpg

Mirikizumab for the treatment of Crohn's disease
03/2025

Mirikizumab for the treatment of Crohn's disease

esophageal-carcinoma.jpg

Multimodal therapy for resectable esophageal cancer
03/2025

Multimodal therapy for resectable esophageal cancer

ilustracion_anticuerpo_monoclonal

Risankizumab in multirefractory Crohn's disease
02/2025

Risankizumab in multirefractory Crohn's disease

ilustracion_perdida_de_peso

Semaglutide versus tirzepatide for weight loss
02/2025

Semaglutide versus tirzepatide for weight loss

esophagus-01.jpg

Clinical outcomes of potential coeliac disease (PCD)
01/2025

Clinical outcomes of potential coeliac disease (PCD)

receptor_de_peptido

GLP-1 receptor agonists before upper gastrointestinal (GI) endoscopy are not associated with increased risk of aspiration
12/2024

Glucagon-like peptide-1 (GLP-1) receptor agonists before upper gastrointestinal (GI) endoscopy are not associated with increased risk of aspiration

superficie_de_microvilli_del_sistema_digestivo

Gastric cancer prevention by community eradication of Helicobacter pylori
10/2024

Gastric cancer prevention by community eradication of Helicobacter pylori

Equipo_de_nutrición_enteral

(EEN) is associated with better long-term outcomes than corticosteroid therapy in children with Morbus Crohn
10/2024

Exclusive enteral nutrition (EEN) is associated with better long-term outcomes than corticosteroid therapy in children with Morbus Crohn

anticuerpos_inmunoglobulinas_proteína-en-forma-de-Y

Ustekinumab Vs. risankizumab for 
Crohn’s disease
9/2024

Ustekinumab versus risankizumab for Crohn’s disease

Enfermedades_Celiacas

New entity of adult ultra-short celiac disease
9/2024

New entity of adult ultra-short celiac disease

células_estómago

Understanding the malignant potential of gastric metaplasia of the oesophagus and its relevance to Barrett's oesophagus surveillance
6/2024

Understanding the malignant potential of gastric metaplasia of the oesophagus and its relevance to Barrett's oesophagus surveillance: Individual-level data analysis

colonoscopía1

Clinical predictors of early and late endoscopic recurrence following ileocolonic resection in Crohn's disease
6/2024
 

Clinical predictors of early and late endoscopic recurrence following ileocolonic resection in Crohn's disease

donación

Standard of care versus octreotide in angiodysplasia-related bleeding (the OCEAN study): A multicenter randomized controlled trial.
5/2024

Standard of care versus octreotide in angiodysplasia-related bleeding (the OCEAN study): A multicenter randomized controlled trial.

cuerpo_con_aguja

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): An open-label, multicentre, randomised controlled trial.
5/2024

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): An open-label, multicentre, random